CMR Surgical company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

cmrsurgical.com

Founded Year

2014

Stage

Series D | Alive

Total Raised

$986.3M

Valuation

$0000 

Last Raised

$600M | 1 yr ago

About CMR Surgical

CMR Surgical is a surgical robotics company developing universal robotic systems for minimal access surgery. The company's vision is to make minimal access (or keyhole) surgery universally accessible and affordable by significantly expanding the range of procedures that can be performed robotically.

CMR Surgical Headquarter Location

1 Evolution Business Park Milton Road

Cambridge, England, CB24 9NG,

United Kingdom

+44 (0)1223 755 300

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing CMR Surgical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

CMR Surgical is included in 6 Expert Collections, including Digital Health.

D

Digital Health

12,917 items

Startups recreating how healthcare is delivered

U

Unicorns- Billion Dollar Startups

1,113 items

R

Robotics

1,795 items

This collection includes startups developing autonomous ground robots, unmanned aerial vehicles, robotic arms, and underwater drones, among other robotic systems. This collection also includes companies developing operating systems and vision modules for robots.

M

Medical Devices

8,567 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

D

Digital Health 150

150 items

The winners of the second annual CB Insights Digital Health 150.

H

Health IT

7,900 items

CMR Surgical Patents

CMR Surgical has filed 108 patents.

The 3 most popular patent topics include:

  • Surgery
  • Surgical instruments
  • Surgical robots
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/9/2018

4/26/2022

Surgery, Surgical robots, Computing input devices, User interfaces, Neurosurgery

Grant

Application Date

3/9/2018

Grant Date

4/26/2022

Title

Related Topics

Surgery, Surgical robots, Computing input devices, User interfaces, Neurosurgery

Status

Grant

Latest CMR Surgical News

09:45 EDT Global AI in Bio Pharmaceuticals Market Analysis Report 2022: Technology Landscape, Competitive Landscape, Business Ov...

May 13, 2022

News provided by Share this article Share this article DUBLIN, May 13, 2022 /PRNewswire/ -- The "AI in Bio Pharmaceuticals" report has been added to ResearchAndMarkets.com's offering. This report forecasts a considerable trend for "AI democratization" where various machine learning/deep learning technologies become available in pre-trained, pre-configured "off-the-shelf" formats, or relatively ready-to-use formats - via cloud-based models, frameworks, and drag-and-drop AI-pipeline building platforms (for example, KNIME), companies, like Google, Tencent, Nvidia, Microsoft, and others, are expanding into healthcare space via not only offering specialized services and tools to pharma counterparties but also directly investing into biotech start-ups and larger companies, creating own centres of excellence and commercial subsidiaries with focus on Life Sciences. AI is regarded by some top executives at big pharma (Novartis, Pfizer, GSK and others) as a tool to uncover not only new molecules but also new targets. The ability of deep neural networks to build ontologies from multimodal data (e.g., "omics" data) is believed to be among the most disruptive areas for AI in drug discovery, alongside data mining from unstructured data, like text (using natural language processing, NLP). In this report, the use of artificial intelligence or any other computational algorithm for drug discovery, biomarker development, and advanced R&D is highlighted along with technology providers in pharma industry, computational methods used by the most advanced AI companies, an overall growth of investment and business development activity in the area of pharmaceutical AI along with some other sections which are listed in the table of content of the report. The technology providers in Pharmaceutical Industry are profiled in the report into 6 categories: Artificial Intelligence (R&D Platforms), Quantum Computing, Supporting Services, "Big Tech" Corporations, Autonomous Labs, and Big Data Providers. The publisher has also highlighted certain challenges which are faced by the pharma sector during drug discovery and the solutions that could be implemented. A new drug takes an average of ten years to reach the market. According to Tufts University's Center for the Study of Medicine Development (CSDD), the cost of producing a new prescription drug that receives FDA clearance is around $2.6 billion as of 2014. The pharmaceutical industry is reaching the end of its life cycle, and the returns on new treatments that do make it to market no longer justify the vast investments that pharma makes in R&D. Notable AI Breakthroughs: Insilico Medicine announces the preclinical candidate for kidney fibrosis discovered using end-to-end Artificial Intelligence engine. The preclinical candidate has the desirable pharmacological properties, pharmacokinetic pro?le and demonstrated auspicious results in in-vitro and in-vivo preclinical studies. (Feb 2021) Cyclica launched an AI-based drug discovery platform that achieved over 60% of actionable hits for its pharma clients. Cyclica has partnered with over 100 global pharma and biotech companies and academia across many therapy areas. These partnerships have resulted in 64% of programmes resulting in actionable hits. (March 2021) Recent Key Activities (Big-Tech Companies expanding in the domain) Microsoft Cloud for healthcare brings together trusted capabilities to customers and partners that enhance patient engagement, empower health team collaboration, and improve clinical and operational data insights to improve decision-making and operational efficiencies Tencent is entering pharma and healthcare space with a focus on AI-based platforms for analysis of research and clinical data. Also, it promotes innovations in hospitals via the digitalization of medical services and pharmaceutical supply chains. It also unites one of the largest online communities of doctors and providers for telemedicine services Recent Developments In May 2021, Microsoft partnered with robotic surgery startup Cmr Surgical on a proof of concept to store clinical data from cmr's next-generation surgical robot, Versius, into a glass, marking an exciting step-change for the future of health data. Rich data from hundreds of surgical robotic procedures can be stored safely and securely into one Microsoft project silica glass platter and could ultimately be harnessed to improve patient outcomes. Also, Microsoft participated (via m12) in the $21.5m series A round for lab automation startup artificial In March 2021, Amgen announced that it has entered into a multi-year partnership with Mila - Quebec Artificial Intelligence Institute In April 2021, NVIDIA announced a strategic partnership with Schrodinger to expand the speed and accuracy of Schrodinger's computational drug discovery platform and enable rapid, accurate evaluation of billions of molecules for the potential development of therapeutics Critical Questions the Report Answers: What are the technological advancements of artificial intelligence in the pharma industry by key players? What are the notable technological evolutions of top players? What are the challenges faced by pharma industry and how they have been addressed using artificial intelligence? What are the applications and use cases for AI in advanced R&D? What are the most used computational methods for AI? Who are the top publicly traded companies in the domain? What are the recent investments, deals, and collaboration for AI in pharma? What is the geographical presence of AI for the pharma industry? Key Topics Covered:

CMR Surgical Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

CMR Surgical Rank

  • When was CMR Surgical founded?

    CMR Surgical was founded in 2014.

  • Where is CMR Surgical's headquarters?

    CMR Surgical's headquarters is located at 1 Evolution Business Park, Cambridge.

  • What is CMR Surgical's latest funding round?

    CMR Surgical's latest funding round is Series D.

  • How much did CMR Surgical raise?

    CMR Surgical raised a total of $986.3M.

  • Who are the investors of CMR Surgical?

    Investors of CMR Surgical include Cambridge Innovation Capital, Watrium, GE Healthcare, SoftBank Group, Tencent Holdings and 11 more.

  • Who are CMR Surgical's competitors?

    Competitors of CMR Surgical include ACTIV Surgical, Vicarious Surgical, Quantum Surgical, Stereotaxis, Medrobotics and 11 more.

You May Also Like

M
Medrobotics

Medrobotics has developed a platform of flexible medical robots that enable surgeons to access, visualize, and perform two-handed surgery in hard-to-reach anatomical places through a single-site access. The core technology is a new generation of flexible robotic snakes with advanced vision systems that are able to navigate tortuous paths while providing accessory channels for a wide range of flexible surgical tools. The robots are self-supporting, which means they are able to support their own weight and move within any three-dimensional space without the need for any other structural support. The company was formerly known as Cardiorobotics and Innvoention Technologies.

Quantum Surgical Logo
Quantum Surgical

Quantum Surgical is a surgical robotics start-up building next-generation smart tools for minimally invasive therapies, beginning with interventional oncology. The robotic platform will enable physicians to better assess, plan, and treat a broad spectrum of medical conditions. The Company is developing end-to-end solutions for interventional oncology.

A
ACTIV Surgical

Activ is a developer of software to augment surgeons. It develops an AI/ML platform called ActivEdge, which is designed to provide real-time intelligence and visualization to surgeons. The company was founded in 2017 and is based in Boston, Massachusetts.

I
Intuitive Surgical

Intuitive Surgical develops, manufactures and markets robotic surgical systems under the da Vinci Surgical brand.

B
Bionaut Labs

Bionaut Labs is a biotech company that designs and manufactures intra- tissue navigation using Bionaut nano/micro robots operating inside the body. The company is based in Los Angeles, California.

Theator Logo
Theator

Theator offers an online platform where surgeons can record surgeries and use them as educational material for improving future procedures. It was founded in 2018 and is based in Palo Alto, California.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.